Effects of urinary protease inhibitor on inflammatory response during on-pump coronary revascularisation. Effect of ulinastatin on inflammatory response

Journal of Cardiovascular Surgery

Volumn 48, Issue 4, 2007, Pages 497-503

  Bingyang, J ^a,b   Jinping, L ^a   Mingzheng, L ^a   Guyan, W ^a   Zhengyi, F ^b  

^a FUWAI HOSPITAL   (China)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiopulmonary bypass; Inflammation; Ulinastatin

Indexed keywords

HEPARIN; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOCYTE ELASTASE; PADGEM PROTEIN; PLACEBO; PROTAMINE SULFATE; PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; CENTRAL VEIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; HUMAN; LUNG FUNCTION; LUNG GAS EXCHANGE; LUNG INJURY; MALE; OFF PUMP SURGERY; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; REPERFUSION INJURY; RESPIRATORY FUNCTION; SURGICAL TECHNIQUE; THROMBOCYTE ACTIVATION;

AGED; BLOOD GAS ANALYSIS; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CYTOKINES; DOUBLE-BLIND METHOD; FEMALE; GLYCOPROTEINS; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTE ELASTASE; MALE; MIDDLE AGED; P-SELECTIN; PILOT PROJECTS; PLATELET ACTIVATION; PROSPECTIVE STUDIES; TRYPSIN INHIBITORS;

EID: 35848933466     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 2002;97:215-52.
2. Harig F, Feyrer R, Mahmoud FO, Blum U, von der Emde J. Reducing the post-pump syndrome by using heparin-coated circuits, steroids, or aprotinin. Thorac Cardiovasc Surg 1999;47: 111-8.
3. Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995;91:1872-85
4. 2-reactive species activate primed platelets in human whole blood. Am J Physiol 1993; 264:H1582-7.
5. Neumann FJ, Marx N, Gawaz M, Brand K, Ott I, Rokitta C et al. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 1997;95:2387-94.
6. Maugeri N, Evangelista V, Piccardoni P, Dell'Elba G, Celardo A, de Gaetano G et al. Transcellular metabolism of arachidonic acid: increased platelet thromboxane generation in the presence of activated polymorphonuclear leukocytes. Blood 1992;80:447-51.
7. Freedman JE, Loscalzo J. Platelet-monocyte aggregates: bridging thrombosis and inflammation. Circulation 2002;105:2130-2.
8. Muramatu M, Mori S, Matsuzawa Y, Horiguchi Y, Nakanishi Y, Tanaka M. Purification and characterization of urinary trypsin inhibitor, UT168, from normal human urine, and its cleavage by human uropepsin. J Biochem 1980;88:1317-29.
9. Nishiyama T, Hirasaki A. Effect of ulinastatin on the elastase release in multiple injuries. Anesth Resuscitation 1994;30:77-80.
10. Ogawa M, Nishibe S, Mori T, Neumann S. Effect of human urinary trypsin inhibitor on granulocyte elastase activity. Res Comm Chem Pathol Pharmacol 1987;55:271-4.
11. Ji B, Long C. The protective effect of ulinastatin on the organism during extracorporeal circulation. Chin J Clin Thorac Cardiovasc Surg 2002;9:51-53.
12. Ohnishi H, Suzuki K, Niho T, Ito C, Yamaguchi K. Protective effects of urinary trypsin inhibitor in experimental shock. Jpn J Pharmacol 1985; 39:137-44.
13. Binns OA, DeLima NF, Buchanan SA, Mauney MC, Cope JT, Thies SD et al. Neutrophil endopeptidase inhibitor improves pulmonary function during reperfusion after eighteen-hour preservation. J Thorac Cardiovasc Surg 1996;112:607-13.
14. Kudo Y, Egashira T, Yamanaka Y. Protective effect of ulinastatin against liver injury caused by ischemia-reperfusion in rats: Jpn J Pharmacol 1992;60:239-45.
15. Li S, Ji H, Lin J, Lenehan E, Ji B, Liu J et al. Combination of acute preoperative plateletpheresis, cell salvage, and aprotinin minimizes blood loss and requirement during cardiac surgery. J Extra Corpor Technol 2005;37:9-14.
16. Nakahama H, Obata K, Sugita M. Ulinastatin ameliorates acute ischemic renal injury in rats. Renal Failure 1996;18:893-8.
17. Yoshitomi H. Experimental studies on protective effects of ulinastatin on "reperfusion injury" using isolated working rat heart model. J Nagoya City Med Center 1993;44:143-55.
18. Li S, Price R, Phiroz D, Swan K, Crane TA. Systemic inflammatory response during cardiopulmonary bypass and strategies. J Extra Corpor Technol 2005;37:180-8.
19. Kirklin JW, Barrat-Boyes BG. Postoperative care. In: Kirklin JW, Barrat-Boyes BG editors. Cardiac surgery. New York: Wiley; 1993. p. 195-248.
20. Sugita T, Watarida S, Katsuyama K, Nakajima Y, Yamamoto R, Mori A. Effect of a human urinary protease inhibitor (Ulinastatin) on respiratory function in pediatric patients undergoing cardiopulmonary bypass. J Cardiovasc Surg (Torino) 2002;43: 437-40.
21. Hiyama A, Takeda J, Yoshifumi K, Morisaki H, Fukushima K. A human urinary protease inhibitor (ulinastatin) inhibits neutrophil extracellular release of elastase during cardiopulmonary bypass. J Cardiothor Vasc Anesth 1997;11:580-4.
22. Horiguchi T, Harada Y. The effect of protease inhibitor on reperfusion injury after unilateral pulmonary ischemia. Transplantation 1993;55:254-8.
23. Enzan K, Mitsuhata H, Masaki Y, Matsumoto J, Shigeomi S, Komatsu H et al. Effects of ulinastatin on granulocyte elastase and fibronectin in patients undergoing cardiopulmonary bypass. Masui (Jpn) 1991;40:1625-31.
24. Rinder CS, Rinder HM, Johnson K, Smith M, Lee DL, Tracey J et al. Role of C3 cleavage in monocyte activation during extracorporeal circulation. Circulation 1999;100:553-8.
25. Rinder CS, Rinder HM, Smith MJ, Tracey JB, Fitch J, Li L et al. Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation. J Thorac Cardiovasc Surg 1999;118:460-6.